SE388542B - Forfarande for framstellning av ett vaccin mot virushepatit - Google Patents
Forfarande for framstellning av ett vaccin mot virushepatitInfo
- Publication number
- SE388542B SE388542B SE7013590A SE1359070A SE388542B SE 388542 B SE388542 B SE 388542B SE 7013590 A SE7013590 A SE 7013590A SE 1359070 A SE1359070 A SE 1359070A SE 388542 B SE388542 B SE 388542B
- Authority
- SE
- Sweden
- Prior art keywords
- hepatit
- vaccine
- virus
- procedure
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86478869A | 1969-10-08 | 1969-10-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE388542B true SE388542B (sv) | 1976-10-11 |
Family
ID=25344077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7013590A SE388542B (sv) | 1969-10-08 | 1970-10-07 | Forfarande for framstellning av ett vaccin mot virushepatit |
Country Status (7)
Country | Link |
---|---|
US (1) | US3636191A (sv) |
JP (1) | JPS5019603B1 (sv) |
BE (1) | BE786240Q (sv) |
DE (1) | DE2049515C3 (sv) |
FR (1) | FR2070112B1 (sv) |
GB (1) | GB1282984A (sv) |
SE (1) | SE388542B (sv) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3951937A (en) * | 1973-12-20 | 1976-04-20 | The Community Blood Council Of Greater New York, Inc. | Large scale purification of hepatitis type B antigen using polyethylene glycol |
US4029764A (en) * | 1974-12-09 | 1977-06-14 | Merck & Co., Inc. | Hepatitis A antigen |
US4017360A (en) * | 1975-05-14 | 1977-04-12 | Merck & Co., Inc. | Method for purifying hepatitis B antigen |
US4024243A (en) * | 1975-06-16 | 1977-05-17 | Merck & Co., Inc. | Process for isolating hepatitis B antigen |
IL49752A (en) * | 1975-07-09 | 1979-07-25 | Kabi Ab | Compositions having affinity for hepatitis virus and method for hepatitis virus removal or concentration |
DE2602892A1 (de) * | 1976-01-27 | 1977-07-28 | Community Blood Council | Konzentriertes hepatitis-b-oberflaechenantigen enthaltende masse und verfahren zu ihrer herstellung |
JPS5653397Y2 (sv) * | 1976-03-11 | 1981-12-12 | ||
SE420977B (sv) * | 1976-03-18 | 1981-11-16 | Kabi Ab | Forfarande for rening och isolering av hepatitvirus for vaccinframstellning |
US4118477A (en) * | 1977-02-14 | 1978-10-03 | Merck & Co., Inc. | Hepatitis B antigen |
GB1554811A (en) * | 1977-02-23 | 1979-10-31 | Merck & Co Inc | Purifying hepatitis b surface antigen |
US4102996A (en) * | 1977-04-20 | 1978-07-25 | Merck & Co., Inc. | Method of preparing hepatitis B core antigen |
US4204989A (en) * | 1978-12-13 | 1980-05-27 | Merck & Co., Inc. | Isolation of hepatitis B e antigen |
US6297355B1 (en) | 1978-12-22 | 2001-10-02 | Biogen, Inc. | Polypeptides displaying HBV antigenicity or hbv antigen specificity |
US4242324A (en) * | 1979-04-04 | 1980-12-30 | Merck & Co., Inc. | Hepatitis B antigen |
US4395395A (en) * | 1979-05-21 | 1983-07-26 | The United States Of America As Represented By The Department Of Health And Human Services | Detection of non-A, non-B hepatitis associated antigen |
PL133476B1 (en) * | 1981-06-10 | 1985-06-29 | Akad Medyczna | Method of obtaining pure antigen hba from human serum |
ZW18282A1 (en) * | 1981-08-31 | 1983-03-23 | Genentech Inc | Preparation of polypeptides in vertebrate cell culture |
AU8746582A (en) * | 1981-09-02 | 1983-03-10 | Biogen N.V. | Hepatitis b virus e type antigen |
US4741901A (en) * | 1981-12-03 | 1988-05-03 | Genentech, Inc. | Preparation of polypeptides in vertebrate cell culture |
JPS59101426A (ja) * | 1982-11-29 | 1984-06-12 | Green Cross Corp:The | B型肝炎感染予防用ワクチンの製造方法 |
JPS6013718A (ja) * | 1983-07-05 | 1985-01-24 | Chemo Sero Therapeut Res Inst | B型肝炎ワクチン |
GB8321789D0 (en) * | 1983-08-12 | 1983-09-14 | Biogen Nv | Vaccines and compositions against hepatitis |
JPS60193925A (ja) * | 1984-03-13 | 1985-10-02 | Chemo Sero Therapeut Res Inst | 凍結乾燥製剤化ワクチン |
US4639371A (en) * | 1984-10-02 | 1987-01-27 | New York Blood Center, Inc. | Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom |
US4695454A (en) * | 1985-04-01 | 1987-09-22 | New York Blood Center, Inc. | Process for preparing hepatitis B surface antigen containing particles in novel forms which are highly immunogenic |
US4683294A (en) * | 1985-04-03 | 1987-07-28 | Smith Kline Rit, S.A. | Process for the extraction and purification of proteins from culture media producing them |
JPH0789951B2 (ja) * | 1986-06-18 | 1995-10-04 | 財団法人阪大微生物病研究会 | 遺伝子発現産物の精製法 |
ATE207535T1 (de) * | 1987-06-22 | 2001-11-15 | Medeva Holdings Bv | Hepatitis-b-oberflächenantigen enthaltendes peptid |
JPS63246335A (ja) * | 1987-09-17 | 1988-10-13 | メルク エンド カムパニー インコーポレーテツド | 肝炎b抗原 |
US5030720A (en) * | 1988-09-01 | 1991-07-09 | Merck & Co., Inc. | Pres2+S hepatitis B vaccine derived from plasma |
EP0491077A1 (en) * | 1990-12-19 | 1992-06-24 | Medeva Holdings B.V. | A composition used as a therapeutic agent against chronic viral hepatic diseases |
US11524398B2 (en) | 2019-03-19 | 2022-12-13 | Covidien Lp | Gear drive mechanisms for surgical instruments |
-
1969
- 1969-10-08 US US864788A patent/US3636191A/en not_active Expired - Lifetime
-
1970
- 1970-09-10 GB GB43442/70A patent/GB1282984A/en not_active Expired
- 1970-09-19 JP JP45081725A patent/JPS5019603B1/ja active Pending
- 1970-09-24 FR FR707034574A patent/FR2070112B1/fr not_active Expired
- 1970-10-07 SE SE7013590A patent/SE388542B/sv unknown
- 1970-10-08 DE DE2049515A patent/DE2049515C3/de not_active Expired
-
1972
- 1972-07-13 BE BE786240A patent/BE786240Q/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE2049515A1 (de) | 1971-04-15 |
DE2049515B2 (de) | 1979-12-20 |
DE2049515C3 (de) | 1980-08-21 |
FR2070112B1 (sv) | 1974-06-21 |
GB1282984A (en) | 1972-07-26 |
US3636191A (en) | 1972-01-18 |
BE786240Q (fr) | 1972-11-03 |
FR2070112A1 (sv) | 1971-09-10 |
JPS5019603B1 (sv) | 1975-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE388542B (sv) | Forfarande for framstellning av ett vaccin mot virushepatit | |
NO149176C (no) | Fremgangsmaate for fremstilling av n-fosfonometyl-glycin | |
DK132303C (da) | Fremgangsmade til fremstilling af en legemiddelform med retarderende virkning | |
FI54301B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara kinazolinderivat | |
BE787901A (fr) | Vaccin antivariolique | |
SE7604818L (sv) | Vaccin | |
FR2282908A1 (fr) | Vaccin contre la colibacillose | |
DK143437C (da) | Fremgangsmaade til fremstilling af en vaccine til hindring af sygdomme fremkaldt af katteleukaemivirus | |
BE794307A (fr) | Vaccin anti-caries | |
SE395699B (sv) | Forfarande for framstellning av kinuklidin-kinolinderivat | |
SE405805B (sv) | Forfarande for framstellning av ett sekretinpreparat med protraherad verkan | |
DK132447C (da) | Fremgangsmade til fremstilling af kalvediarrevirusvaccine | |
SE398514B (sv) | Forfarande for framstellning av ett avdodat blandvaccin for immunisering av fjederfe mot infektioner i andningsvegarna | |
FI45765C (sv) | Förfarande för framställning av tetanusvaccin. | |
SE396694B (sv) | Forfarande for framstellning av en farmaceutisk beredning innehallande ett modifierat allergeniskt material | |
SE400979B (sv) | Forfarande for framstellning av modifierade sampolymerer baserade pa ett c1-c4-alkylakrylat och en omettad flerbasisk karbonsyra anvendbara vid framstellning av lekemedel | |
SE380795B (sv) | Forfarande for framstellning av tiokarbamider | |
NO141565C (no) | Fremgangsmaate for fremstilling av en vaksine mot klovsyke | |
FI48105C (sv) | Förfarande för framställning av ett vaccin | |
SE384365B (sv) | Sett att framstella ett farmaceutiskt anvendbart kalciumsalt av 6-acetyl-amino-hexansyra | |
BE775747A (fr) | Preparation stable de virus | |
SE386075B (sv) | Forfarande for framstellning av ett icke-anafylaktiskt pplo-vaccin | |
SE392104B (sv) | Forfarande for framstellning av ett bensfuranderivat | |
SE382046B (sv) | Forfarande for framstellning av 1-aryloxi-2-propanol | |
SE405454B (sv) | Sett och anordning for att bearbeta platstycken for tillverkning av ett ror med skruvlinjeformad som |